Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Winship Cancer Institute of Emory University are Among the Early Adopters of Manifold’s Purpose-Built Platform
Manifold, an AI-powered clinical research platform, today announced a $15…
Table of Contents
Introduction
Leadership Transition at ScreenPoint Medical
Vision and Expectations Under New Leadership
Impact on Breast Cancer Detection Technology
Reactions and Endorsements
FAQs
Introduction
ScreenPoint Medical, a leading provider of artificial intelligence (AI) solutions for breast cancer detection, has recently…
What You Should Know:
– Geisinger Health Plan (GHP) with OncoHealth®, the leading platform for managing the cost and complexity of cancer, will provide supportive cancer care services to GHP’s more than 550,000 members.
– GHP…
Continue Reading
What You Should Know:
– Blue Earth Diagnostics, a Bracco company and leader in innovative PET radiopharmaceuticals, announced a data-sharing agreement with Siemens Healthineers.
– This collaboration focuses on anonymized data from Blue Earth’s Phase 3…
Continue Reading
Diagnostics startup Geneoscopy earned its first-ever FDA approval this week.
The St. Louis-based company received approval for ColoSense, its noninvasive colorectal cancer screening test. The test — which the FDA designated as a breakthrough device…
Continue Reading
By Shania Kennedy
May 06, 2024 – Researchers from the University of Texas (UT) Southwestern Medical Center have developed a computational tool to predict breast cancer immunotherapy response by analyzing how cancer and immune cells interact.
The…
What You Should Know:
– OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing…
Continue Reading
Among the already available liquid biopsy test is aimed at early detection of colorectal cancer. Colorectal cancer screening is crucial due to the high incidence and mortality rates of the disease, which is increasingly…
Continue Reading
What You Should Know:
– Thyme Care, the leading value-based cancer care enabler, today announced Julia Frydman, MD as the company’s first medical director for palliative care.
– An academic researcher and former assistant professor from…
Continue Reading
Value-based cancer care platform Thyme Care is launching Enhanced Supportive Care, a virtual palliative care support program to assist its members and caregivers with managing physical and psychological symptoms accompanying cancer diagnosis and treatment. The…
Continue Reading
